dc.contributor.author | Akbarzadeh, A | |
dc.contributor.author | Zarghami, N | |
dc.contributor.author | Mikaeili, H | |
dc.contributor.author | Asgari, D | |
dc.contributor.author | Goganian, AM | |
dc.contributor.author | Khiabani, HK | |
dc.contributor.author | Samiei, M | |
dc.contributor.author | Davaran, S | |
dc.date.accessioned | 2018-08-26T09:37:28Z | |
dc.date.available | 2018-08-26T09:37:28Z | |
dc.date.issued | 2012 | |
dc.identifier | 10.2147/NSA.S24328 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58107 | |
dc.description.abstract | Poly (N-isopropylacrylamide-methyl methacrylic acid, PNIPAAm-MAA)-grafted magnetic nanoparticles were synthesized using silane-coated magnetic nanoparticles as a template for radical polymerization of N-isopropylacrylamide and methacrylic acid. Properties of these nanoparticles, such as size, drug-loading efficiency, and drug release kinetics, were evaluated in vitro for targeted and controlled drug delivery. The resulting nanoparticles had a diameter of 100 nm and a doxorubicin-loading efficiency of 75%, significantly higher doxorubicin release at 40ط¢آ°C compared with 37ط¢آ°C, and pH 5.8 compared with pH 7.4, demonstrating their temperature and pH sensitivity, respectively. In addition, the particles were characterized by X-ray powder diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, and vibrating sample magnetometry. In vitro cytotoxicity testing showed that the PNIPAAm- MAA-coated magnetic nanoparticles had no cytotoxicity and were biocompatible, indicating their potential for biomedical application. ط¢آ© 2012 Akbarzadeh et al, publisher and licensee Dove Medical Press Ltd. | |
dc.language.iso | English | |
dc.relation.ispartof | Nanotechnology, Science and Applications | |
dc.subject | biomaterial | |
dc.subject | doxorubicin | |
dc.subject | magnetic nanoparticle | |
dc.subject | nanocoating | |
dc.subject | poly (n isopropylacrylamide methyl methacrylic acid) | |
dc.subject | silane | |
dc.subject | unclassified drug | |
dc.subject | article | |
dc.subject | cancer cell culture | |
dc.subject | controlled drug release | |
dc.subject | controlled study | |
dc.subject | cytotoxicity test | |
dc.subject | drug delivery system | |
dc.subject | drug determination | |
dc.subject | drug research | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | drug targeting | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | in vitro study | |
dc.subject | infrared spectroscopy | |
dc.subject | magnetometry | |
dc.subject | particle size | |
dc.subject | pH measurement | |
dc.subject | polymerization | |
dc.subject | scanning electron microscopy | |
dc.subject | structure analysis | |
dc.subject | temperature sensitivity | |
dc.subject | vibrating sample magnetometry | |
dc.subject | X ray powder diffraction | |
dc.title | Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin | |
dc.type | Review | |
dc.citation.volume | 5 | |
dc.citation.issue | 1 | |
dc.citation.spage | 13 | |
dc.citation.epage | 25 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.2147/NSA.S24328 | |